223 related articles for article (PubMed ID: 19363260)
1. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
[TBL] [Abstract][Full Text] [Related]
2. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
[TBL] [Abstract][Full Text] [Related]
3. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
Ding Y; Qiao A; Fan GH
Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617
[TBL] [Abstract][Full Text] [Related]
4. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
Adlard PA; Cherny RA; Finkelstein DI; Gautier E; Robb E; Cortes M; Volitakis I; Liu X; Smith JP; Perez K; Laughton K; Li QX; Charman SA; Nicolazzo JA; Wilkins S; Deleva K; Lynch T; Kok G; Ritchie CW; Tanzi RE; Cappai R; Masters CL; Barnham KJ; Bush AI
Neuron; 2008 Jul; 59(1):43-55. PubMed ID: 18614028
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice.
Hanna A; Horne P; Yager D; Eckman C; Eckman E; Janus C
Genes Brain Behav; 2009 Oct; 8(7):676-84. PubMed ID: 19531156
[TBL] [Abstract][Full Text] [Related]
7. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
8. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
[TBL] [Abstract][Full Text] [Related]
10. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
11. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
13. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
[TBL] [Abstract][Full Text] [Related]
14. The effect of metals on spatial memory in a transgenic mouse model of Alzheimer's disease.
Railey AM; Groeber CM; Flinn JM
J Alzheimers Dis; 2011; 24(2):375-81. PubMed ID: 21239856
[TBL] [Abstract][Full Text] [Related]
15. Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
Opazo C; Luza S; Villemagne VL; Volitakis I; Rowe C; Barnham KJ; Strozyk D; Masters CL; Cherny RA; Bush AI
Aging Cell; 2006 Feb; 5(1):69-79. PubMed ID: 16441845
[TBL] [Abstract][Full Text] [Related]
16. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
17. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
Ambrée O; Richter H; Sachser N; Lewejohann L; Dere E; de Souza Silva MA; Herring A; Keyvani K; Paulus W; Schäbitz WR
Neurobiol Aging; 2009 Aug; 30(8):1192-204. PubMed ID: 18079024
[TBL] [Abstract][Full Text] [Related]
18. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
19. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H
J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722
[TBL] [Abstract][Full Text] [Related]
20. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]